Fineotex Chemical Limited has informed the Exchange about Investor Presentation
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fineotex Chemical Limited reported exceptional Q4 FY26 results with revenue surging 162% YoY to Rs. 313.73 Cr, driven by the integration of CrudeChem Technologies (acquired 53.33% stake in U.S.-based oilfield specialty chemicals business). Full-year FY26 revenue grew 45% to Rs. 772.23 Cr. However, EBITDA margin compressed significantly from 23.85% in FY25 to 17.45% in FY26 (Q4: 13.93% vs 17.77% prior year), impacted by raw material price volatility from Middle East geopolitical tensions. The company doubled manufacturing capacity at its new USA facility to capture rising demand in the $11.5B North American oilfield chemicals market. Management successfully passed on increased input costs to customers. Company remains debt-free with ICRA rating upgraded to A+ (Positive). Bonus shares (4:1) and stock split (1:2) were also completed.
Strong topline growth demonstrates successful M&A execution and market expansion, but significant margin compression could concern investors focused on profitability metrics. The company is positioned to benefit from favorable trade deals (EU-India FTA, UK duty-free access) and growing oilfield chemicals demand, though near-term margin recovery will be key to watch.